Larvol Delta - AltruBio-Announces-First-Patient-Dosed-in-Phase-1b-Study-of-Neihulizumab-in-Patients-with-SteroidRefractory-Acute-GraftversusHost-Disease

neihulizumab (AbGn-168H) - AbGenomics

https://www.prweb.com/releases/altrubio_announces_first_patient_dosed_in_phase_1b_study_of_neihulizumab_in_patients_with_steroid_refractory_acute_graft_versus_host_disease/prweb17430035.htm

Sep 29, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next